Brief: Cynata Therapeutics Appoints Kilian Kelly As Chief Executive Officer And Managing Director
30/06/2023 02:34
June 30 (Reuters) - Cynata Therapeutics Ltd CYP.AX :
* APPOINTMENT OF KILIAN KELLY TO POSITION OF CHIEF EXECUTIVE
OFFICER AND MANAGING DIRECTOR
* APPOINTMENT OF KILIAN KELLY FOLLOWING RETIREMENT OF ROSS
MACDONALD
Source text for Eikon: ID:nASXSBkhK
Further company coverage: CYP.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cynata Therapeutics
See all newsBrief: Cynata Therapeutics Says Firm Commitments Received To Raise Further A$550,000 Via Placement
Brief: Cynata Therapeutics Enters Consultancy Agreement With LIR Bio Advisory
Brief: Cynata Therapeutics Establishes Share Sale Facility For Unmarketable Parcel Holders
Brief: Cynata Therapeutics Terminates Of At-The-Market Subscription Deed
Brief: Cynata Therapeutics Posts FY2026 Loss From Ordinary Activities After Tax A$9.1 Million